Alzamend Neuro Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Net Income	-4.51	-9.95	-14.88	-12.36	-5.05	Upgrade
Depreciation & Amortization	0.05	0.05	0.02	0	-	Upgrade
Stock-Based Compensation	0.33	0.96	3.58	4.41	2.03	Upgrade
Other Operating Activities	0.01	0	-	0.01	0.45	Upgrade
Change in Accounts Payable	-2.29	0.05	1.71	0.69	-0.41	Upgrade
Change in Other Net Operating Assets	-0.15	0.62	0.64	0.63	0.26	Upgrade
Operating Cash Flow	-6.57	-8.27	-8.92	-6.61	-2.71	Upgrade
Capital Expenditures	-0.3	-0.15	-	-0.11	-	Upgrade
Other Investing Activities	-	-	-	-	0.1	Upgrade
Investing Cash Flow	-0.3	-0.15	-	-0.11	0.1	Upgrade
Short-Term Debt Issued	-	0.3	-	-	2.25	Upgrade
Total Debt Issued	-	0.3	-	-	2.25	Upgrade
Short-Term Debt Repaid	-	-	-	-0.06	-0	Upgrade
Total Debt Repaid	-	-	-	-0.06	-0	Upgrade
Net Debt Issued (Repaid)	-	0.3	-	-0.06	2.25	Upgrade
Issuance of Common Stock	2.7	1.25	0	18.91	2.2	Upgrade
Financing Cash Flow	10.44	3.65	0	18.85	4.45	Upgrade
Net Cash Flow	3.57	-4.76	-8.92	12.13	1.84	Upgrade
Free Cash Flow	-6.87	-8.42	-8.92	-6.72	-2.71	Upgrade
Free Cash Flow Per Share	-15.24	-111.97	-123.53	-101.83	-50.40	Upgrade
Levered Free Cash Flow	-5.19	-4.69	-4.33	-2.19	-0.41	Upgrade
Unlevered Free Cash Flow	-5.17	-4.68	-4.33	-2.16	-0.31	Upgrade
Change in Working Capital	-2.44	0.67	2.35	1.33	-0.15	Upgrade

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q